Pharmaceutical infrastructure company PharmAGRI announced its plans to utilize up to 10,000 of Tesla's third-generation Optimus humanoid robots. The robots are intended for deployment across the company's farm operations, active pharmaceutical ingredient synthesis, and prescription drug manufacturing facilities. According to the announcement, the robots are designed to meet compliance requirements from the Drug Enforcement Administration and the Food and Drug Administration. The initiative is expected to reduce reliance on undocumented labor, and the company plans to implement retraining programs to support the workforce transition. This represents a significant order for Tesla's robotics division, a business segment that CEO Elon Musk has identified as crucial to the company's future.